Jonathan Mandel is a Partner at Centerview focused on healthcare services and technology. He has more than 15 years of experience advising healthcare companies on mergers and acquisitions, shareholder activism, equity and debt financings, and other complex strategic issues.
Selected advisory assignments include:
Healthcare Technology
- Qualtrics on its $6.75 billion acquisition of Press Ganey Forsta
- Dassault Systemes on its $5.8 billion acquisition of Medidata
- Gainwell on its $3.4 billion acquisition of HMS
- MedAssets on its $2.7 billion sale to Pamplona Capital
- The Advisory Board Company on its $2.6 billion sale to Optum and Vista Equity
- VaxCare on its $1.7 billion sale to Blackstone Growth
- The Special Committee of Convey Health on its $1.1 billion sale to TPG
- WellSky on its recapitalization with LGP and TPG
- Press Ganey on its sale to Ares and LGP
- Astorg on its recapitalization of ERT alongside Nordic Capital and Novo Holdings
- ERT on its acquisition of Bioclinica
- Kepro on its sale to CNSI
- Aetion on its sale to Datavant
- Accolade on its $460 million acquisition of 2nd MD
- IPOs for Accolade, Oak Street Health, Health Catalyst, and Cotiviti
Healthcare Services:
- Blackstone, Carlyle, and H&F on their $34 billion acquisition of Medline
- Walgreens on its $24 billion sale to Sycamore Partners
- Oak Street Health on its $11 billion sale to CVS Health
- TeamHealth on its $6.1 billion sale to Blackstone
- Cigna on its $3.7 billion sale of the Medicare and CareAllies Businesses to HCSC
- Humana on its $1.1 billion divestiture of Concentra to Select Medical and WCAS
- Humana on its $600 million Partners in Primary Care joint venture with WCAS
Prior to joining Centerview, Jonathan was a Vice President in the Healthcare Group at Goldman Sachs, and began his career at Fitch Ratings. He received his BA from Vassar College.